Issues related to FDA regulation of pharmaceuticals. Drug pricing and Medicare, including implementation of the Inflation Reduction Act (PL 117-169), and implementation of Executive Order 14273, Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients. Issues related to intellectual property and patent reform, including: S.1040, Drug Competition Enhancement Act; S.1041; Affordable Prescriptions for Patients Act. Vaccine Policy, Coverage and Access and the Vaccine Injury Compensation Fund. H.R.2214 - DRUG Act.
Source-reported fields
Filing overview
- Type
- 2nd Quarter - Report
- Posted
- Jul 21, 2026
- Income
- $60,000.00
- Expenses
- Not reported
- Registrant
- TODD STRATEGY GROUP
- Client
- PFIZER INC.
- Filing UUID
- dd2425d1-a5b8-44b3-8e63-c481f0bce531
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Issues related to tariff and trade policy. International Supply Chain.
Issues related to tariff and trade policy.
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.